Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Comment on: Valette et al. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLOS ONE 2012; 7(11):E48221.

Meyre D, Froguel P, Horber FF, Kral JG.

PLoS One. 2014 Mar 31;9(3):e93324. doi: 10.1371/journal.pone.0093324. eCollection 2014. No abstract available.

2.

Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery.

Valette M, Poitou C, Le Beyec J, Bouillot JL, Clement K, Czernichow S.

PLoS One. 2012;7(11):e48221. doi: 10.1371/journal.pone.0048221. Epub 2012 Nov 21.

3.

Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations.

Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C.

Obes Surg. 2011 Jul;21(7):930-4. doi: 10.1007/s11695-010-0295-8.

4.

Treatment options for children with monogenic forms of obesity.

Hainerová IA, Lebl J.

World Rev Nutr Diet. 2013;106:105-12. doi: 10.1159/000342556. Epub 2013 Feb 11. Review.

PMID:
23428688
5.

Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.

Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjöström L, Bouchard C, Carlsson LM.

Int J Obes (Lond). 2011 May;35(5):676-83. doi: 10.1038/ijo.2010.166. Epub 2010 Aug 24. Erratum in: Int J Obes (Lond). 2012 Jul;36(7):1016.

PMID:
20733583
6.

Influence of obesity-susceptibility loci (MC4R and INSIG2) on the outcome of weight loss and amelioration of co-morbidity in obese patients treated by a gastric-bypass.

Goergen M, Manzoni D, De Blasi V, Fabiano P, Poulain V, De Magistris L, Simonelli V, Dahan K, Azagra JS.

Bull Soc Sci Med Grand Duche Luxemb. 2011;(2):7-24.

PMID:
22272442
7.

Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss.

Haupt A, Thamer C, Heni M, Tschritter O, Machann J, Schick F, Machicao F, Häring HU, Staiger H, Fritsche A.

Obesity (Silver Spring). 2009 Oct;17(10):1942-5. doi: 10.1038/oby.2009.233. Epub 2009 Jul 30.

8.

Psychosocial state after bariatric surgery is associated with the serotonin-transporter promoter polymorphism.

Defrancesco M, Liebaert J, Kemmler G, Aigner F, Niederstätter H, Parson W, Kinzl JF.

Eat Weight Disord. 2013 Sep;18(3):311-6. doi: 10.1007/s40519-013-0045-8. Epub 2013 Jul 9.

PMID:
23835931
9.

Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene.

Reinehr T, Hebebrand J, Friedel S, Toschke AM, Brumm H, Biebermann H, Hinney A.

Obesity (Silver Spring). 2009 Feb;17(2):382-9. doi: 10.1038/oby.2008.422. Epub 2008 Nov 6.

10.

Polymorphism Val103Ile of the melanocortin-4 receptor gene in the Serbian population.

Stokić E, Djan M, Vapa Lj, Djan I, Plećas A, Srdić B.

Mol Biol Rep. 2010 Jan;37(1):33-7. doi: 10.1007/s11033-009-9500-z. Epub 2009 Mar 13.

PMID:
19283510
11.

Melanocortin signalling, single nucleotide polymorphism, and eating disorders.

Inui A.

Int J Psychiatry Med. 2004;34(4):399-403. No abstract available.

PMID:
15825588
12.

Obesity susceptibility loci on body mass index and weight loss in Spanish adolescents after a lifestyle intervention.

Moleres A, Rendo-Urteaga T, Zulet MA, Marcos A, Campoy C, Garagorri JM, Martínez JA, Azcona-Sanjulián MC, Marti A; EVASYON Study Group..

J Pediatr. 2012 Sep;161(3):466-470.e2. doi: 10.1016/j.jpeds.2012.04.004. Epub 2012 May 18.

PMID:
22608907
13.

Genomic localization and SNP discovery in the bovine melanocortin receptor 4 gene (MC4R).

Valle E, Habermann FA, Moore SS, Crews DH, Benkel BF.

Anim Genet. 2004 Aug;35(4):351-2. No abstract available.

PMID:
15265081
14.

Identifying genetic factors in common diseases: more helpful in relation to etiology than prediction.

Nöthen MM, Propping P.

Dtsch Arztebl Int. 2013 May;110(19):329-30. doi: 10.3238/arztebl.2013.0329. No abstract available.

15.

Molecular genetic aspects of weight regulation.

Hebebrand J, Hinney A, Knoll N, Volckmar AL, Scherag A.

Dtsch Arztebl Int. 2013 May;110(19):338-44. doi: 10.3238/arztebl.2013.0338. Epub 2013 May 10. Review.

16.

Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index.

Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T, Schäfer H, Hebebrand J.

J Med Genet. 2004 Oct;41(10):795-800. No abstract available.

17.

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL.

Arch Gen Psychiatry. 2012 Sep;69(9):904-12.

18.

Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations.

Hebebrand J, Geller F, Dempfle A, Heinzel-Gutenbrunner M, Raab M, Gerber G, Wermter AK, Horro FF, Blundell J, Schäfer H, Remschmidt H, Herpertz S, Hinney A.

Mol Psychiatry. 2004 Aug;9(8):796-800.

PMID:
15037865
19.

Melanocortin 3 receptor gene and melanocortin 4 receptor gene mutations: the Asian Perspective.

Lee YS.

Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:26-31. doi: 10.1002/dmrr.2351. Review.

PMID:
23280863
20.

Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.

Chowdhury NI, Tiwari AK, Souza RP, Zai CC, Shaikh SA, Chen S, Liu F, Lieberman JA, Meltzer HY, Malhotra AK, Kennedy JL, Müller DJ.

Pharmacogenomics J. 2013 Jun;13(3):272-9. doi: 10.1038/tpj.2011.66. Epub 2012 Feb 7.

PMID:
22310352

Supplemental Content

Support Center